Pursglove Geordan Garrett — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Pursglove Geordan Garrett has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Pursglove Geordan Garrett

Geordan Garrett Pursglove is the CEO and Chairman of the Board of Lixte Biotechnology Holdings, Inc., a biopharmaceutical company focused on developing Protein Phosphatase 2A inhibitors for cancer treatment. He has held the role of Director and has been involved in the company's strategic direction.

RoleCEO and Chairman of the Board, Director
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-02LIXTLIXTE BIOTECHNOLOGY HOLDINGS, INC.A — Grant or award350.0K$0.00
2026-04-17LIXTLIXTE BIOTECHNOLOGY HOLDINGS, INC.A — Grant or award350.0K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Pursglove Geordan Garrett?

Geordan Garrett Pursglove is the CEO and Chairman of the Board of Lixte Biotechnology Holdings, Inc., a biopharmaceutical company focused on developing Protein Phosphatase 2A inhibitors for cancer treatment. He has held the role of Director and has been involved in the company's strategic direction.…

How many SEC Form 4 filings has Pursglove Geordan Garrett submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Pursglove Geordan Garrett's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Pursglove Geordan Garrett profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.